Position in CRBU
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,757,574
+$1,662,617 QoQ
Shares Held
925,039
+1448.9% QoQ
Ownership
0.933%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 137 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $659,552,548 across 178 Biotechnology names. CRBU ranks #47 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,900,824 | $178,905,554 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
151,191 | $116,816,214 | |
| 3 | LEGN |
Legend Biotech Corp
|
1,527,336 | $27,629,508 | |
| 4 | TBPH |
Theravance Biopharma, Inc.
|
1,276,576 | $20,718,828 | |
| 5 | RIGL |
Rigel Pharmaceuticals Inc
|
666,426 | $18,020,159 | |
| 6 | IMCR |
Immunocore Holdings plc
|
501,091 | $15,107,893 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
1,547,593 | $15,042,603 | |
| 8 | PBYI |
Puma Biotechnology, Inc.
|
2,041,759 | $13,046,840 |
All Filings in CRBU
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,757,574 | 925,039 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $94,957 | 59,722 | Shares | Defined | 2026-02-10 | |
| 2025-03-31 | $61,832 | 67,725 | Shares | Defined | 2025-05-21 | |
| 2024-03-31 | $803,063 | 156,238 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $826,936 | 144,317 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||